Latest News about MYOV
Recent news which mentions MYOV
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
SVB Leerink Maintains Market Perform Rating for Myovant Sciences, Lowers Price Target To $12
April 13, 2022
Tickers
MYOV
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 12, 2022
From Benzinga
Why Myovant Sciences Stock Is Crashing Today
April 12, 2022
From Motley Fool
What's Going On With Myovant Sciences Stock Today?
April 12, 2022
From Benzinga
From Benzinga
Urovant Reports Publication of New Efficacy, Safety Data On Gemtesa For Overactive Bladder
March 22, 2022
Tickers
MYOV
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 25, 2022
From Benzinga
Myovant Sciences Ltd. (MYOV) Q3 2021 Earnings Call Transcript
January 26, 2022
Tickers
MYOV
From Motley Fool
Earnings Scheduled For January 26, 2022
January 26, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 03, 2021
From Benzinga
Myovant Sciences Ltd. (MYOV) Q2 2021 Earnings Call Transcript
October 26, 2021
Tickers
MYOV
From Motley Fool
Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat?
October 26, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 26, 2021
From Benzinga
Myovant Sciences Earnings Perspective: Return On Capital Employed
October 26, 2021
Tickers
MYOV
From Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 26, 2021
From Benzinga
Earnings Scheduled For October 26, 2021
October 26, 2021
From Benzinga
Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More
September 25, 2021
From Benzinga
3 Stocks Insiders Are Buying
September 13, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
3 Stocks Insiders Are Buying
September 07, 2021
From Benzinga